Continuous glucose monitoring (CGM) is crucial in order to avoid complications caused by change in blood glucose for patients suffering from diabetes mellitus. The long-term consequences of high blood glucose levels include damage to the heart, eyes, kidneys, nerves and other organs, among others, caused by malign glycation of vital protein structures. Fluorescent monitors based on arylboronic acids are promising candidates for optical CGM, since arylboronic acids are capable of forming arylboronate esters with 1,2-cis-diols or 1,3-diols fast and reversibly, even in aqueous solution. These properties enable arylboronic acid dyes to provide immediate information of glucose concentrations. Thus, the replacement of the commonly applied semi-...
There is an urgent need to develop technology for continuous in vivo glucose monitoring in subjects ...
There is an urgent need to develop technology for continuous in vivo glucose monitoring in subjects ...
There is an urgent need to develop technology for continuous in vivo glucose monitoring in subjects ...
Diabetes is an incurable disease that promotes acute and chronic complications, namely blindness, he...
Diabetes is an incurable disease that promotes acute and chronic complications, namely blindness, he...
Diabetes is a widespread disease, whereby the body is incapable of regulating the metabolism of gluc...
Diabetes is an incurable disease that promotes acute and chronic complications, namely blindness, he...
Diabetes is an incurable disease that promotes acute and chronic complications, namely blindness, he...
Diabetes is an incurable disease known to have severe acute and chronic side effects, namely blindne...
Diabetes is an incurable disease known to have severe acute and chronic side effects, namely blindne...
Diabetes is an incurable disease known to have severe acute and chronic side effects, namely blindne...
There is an urgent need to develop technology for continuous in vivo glucose monitoring in subjects ...
There is an urgent need to develop technology for continuous in vivo glucose monitoring in subjects ...
There is an urgent need to develop technology for continuous in vivo glucose monitoring in subjects ...
There is an urgent need to develop technology for continuous in vivo glucose monitoring in subjects ...
There is an urgent need to develop technology for continuous in vivo glucose monitoring in subjects ...
There is an urgent need to develop technology for continuous in vivo glucose monitoring in subjects ...
There is an urgent need to develop technology for continuous in vivo glucose monitoring in subjects ...
Diabetes is an incurable disease that promotes acute and chronic complications, namely blindness, he...
Diabetes is an incurable disease that promotes acute and chronic complications, namely blindness, he...
Diabetes is a widespread disease, whereby the body is incapable of regulating the metabolism of gluc...
Diabetes is an incurable disease that promotes acute and chronic complications, namely blindness, he...
Diabetes is an incurable disease that promotes acute and chronic complications, namely blindness, he...
Diabetes is an incurable disease known to have severe acute and chronic side effects, namely blindne...
Diabetes is an incurable disease known to have severe acute and chronic side effects, namely blindne...
Diabetes is an incurable disease known to have severe acute and chronic side effects, namely blindne...
There is an urgent need to develop technology for continuous in vivo glucose monitoring in subjects ...
There is an urgent need to develop technology for continuous in vivo glucose monitoring in subjects ...
There is an urgent need to develop technology for continuous in vivo glucose monitoring in subjects ...
There is an urgent need to develop technology for continuous in vivo glucose monitoring in subjects ...
There is an urgent need to develop technology for continuous in vivo glucose monitoring in subjects ...
There is an urgent need to develop technology for continuous in vivo glucose monitoring in subjects ...
There is an urgent need to develop technology for continuous in vivo glucose monitoring in subjects ...